Effectiveness of Laxatives in the Elderly - NIHR Health Technology ...
Effectiveness of Laxatives in the Elderly - NIHR Health Technology ...
Effectiveness of Laxatives in the Elderly - NIHR Health Technology ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
NHS R&D HTA Programme<br />
The overall aim <strong>of</strong> <strong>the</strong> NHS R&D <strong>Health</strong> <strong>Technology</strong> Assessment (HTA) programme<br />
is to ensure that high-quality research <strong>in</strong>formation on <strong>the</strong> costs, effectiveness and<br />
broader impact <strong>of</strong> health technologies is produced <strong>in</strong> <strong>the</strong> most efficient way for those<br />
who use, manage and work <strong>in</strong> <strong>the</strong> NHS. Research is undertaken <strong>in</strong> those areas where <strong>the</strong><br />
evidence will lead to <strong>the</strong> greatest benefits to patients, ei<strong>the</strong>r through improved patient<br />
outcomes or <strong>the</strong> most efficient use <strong>of</strong> NHS resources.<br />
The Stand<strong>in</strong>g Group on <strong>Health</strong> <strong>Technology</strong> advises on national priorities for health<br />
technology assessment. Six advisory panels assist <strong>the</strong> Stand<strong>in</strong>g Group <strong>in</strong> identify<strong>in</strong>g<br />
and prioritis<strong>in</strong>g projects. These priorities are <strong>the</strong>n considered by <strong>the</strong> HTA Commission<strong>in</strong>g<br />
Board supported by <strong>the</strong> National Coord<strong>in</strong>at<strong>in</strong>g Centre for HTA (NCCHTA).<br />
This report is one <strong>of</strong> a series cover<strong>in</strong>g acute care, diagnostics and imag<strong>in</strong>g, methodology,<br />
pharmaceuticals, population screen<strong>in</strong>g, and primary and community care. It was identified<br />
as a priority by <strong>the</strong> Pharmaceutical Panel (see <strong>in</strong>side back cover).<br />
The views expressed <strong>in</strong> this publication are those <strong>of</strong> <strong>the</strong> authors and not necessarily those<br />
<strong>of</strong> <strong>the</strong> Stand<strong>in</strong>g Group, <strong>the</strong> Commission<strong>in</strong>g Board, <strong>the</strong> Panel members or <strong>the</strong> Department<br />
<strong>of</strong> <strong>Health</strong>.<br />
Series Editors: Andrew Stevens, Ruairidh Milne and Ken Ste<strong>in</strong><br />
Assistant Editor: Jane Robertson<br />
The editors have tried to ensure <strong>the</strong> accuracy <strong>of</strong> this report but cannot accept<br />
responsibility for any errors or omissions. They would like to thank <strong>the</strong> referees<br />
for <strong>the</strong>ir constructive comments on <strong>the</strong> draft document.<br />
ISSN 1366-5278<br />
© Crown copyright 1997<br />
Enquiries relat<strong>in</strong>g to copyright should be addressed to <strong>the</strong> NCCHTA (see address given below).<br />
Published by Core Research, Alton, on behalf <strong>of</strong> <strong>the</strong> NCCHTA.<br />
Pr<strong>in</strong>ted on acid-free paper <strong>in</strong> <strong>the</strong> UK by The Bas<strong>in</strong>gstoke Press, Bas<strong>in</strong>gstoke.<br />
Copies <strong>of</strong> this report can be obta<strong>in</strong>ed from:<br />
The National Coord<strong>in</strong>at<strong>in</strong>g Centre for <strong>Health</strong> <strong>Technology</strong> Assessment,<br />
Mailpo<strong>in</strong>t 728, Boldrewood,<br />
University <strong>of</strong> Southampton,<br />
Southampton, SO16 7PX, UK.<br />
Fax: +44 (0) 1703 595 639 Email: hta@soton.ac.uk<br />
http://www.soton.ac.uk/~hta